MENU
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Crinetics Pharmaceuticals (CRNX) Ownership - Who owns Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.85B
P/E Ratio
N/A
Total Cash
1.35B
Projected Growth
N/A
Total Debt
51.72M
Revenue
1.04M
Risk (Beta)
-0.33
Dividend Yield
N/A
Total Cash/Share
14.55
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
CRNX
Capitalization
2.85B
P/E Ratio
N/A
Risk (Beta)
-0.33
Dividend Yield
N/A
Total Cash
1.35B
Total Cash/Share
14.55
Total Debt
51.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
1.04M
ROE
N/A
Book Value
1.33B
P/B Ratio
2.15
Cash Flow
N/A
Earnings
-3.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.28B
Current Ratio
23.04
Current Revenue Per Employee
1900.00
Dividends Per Share - Security
N/A
EBITDA
-336.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.83
Shares Held By Institutions
7.97B
Shares Outstanding - Current
93M
Total Liabilities
110M
Total Volume MTD
N/A
Value
-1
Gain YTD
-40.113
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for endocrine-related diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com